We describe an enzymic quantification of phosphatidyiglycerol in amniotic fluid. Phosphatidylglycerol is hydrolyzed in alkali and theresulting glycerol isthenenzymatically phos- by charcoal, the radioactivity of the glycerophosphate is measuredina liquid scintillation counter. Triglyceride inthe amniotic fluid ishydrolyzed by lipase beforeextraction and thus does not interfere with the analysis. This method is specific forphosphatidylglycerol. Preliminary studies suggest that a phosphatidylglycerol value 10 nmol/mL correlates with fetal lung maturity.
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The ratio of lecithin (L) to sphingomyelin (S) in amniotic fluid is the test most often used to assess fetal lung maturity 
Materials and Methods

Instrumentation
Beta radiation from phosphorus-32 was quantified with a Model LS-100 Liquid Scintillation
Counter (Beckman Instruments Inc., Fullerton, CA 92634).
Materials
Enzymes.
Lipase (microbial, 
Procedures
Reagent A: Dilute 3.7 g of KOH and 0.5 mL of Triton X-100 to 100 mL with water. Reagent B: Dilute 1.5 g of glycine and 0.2 mL of 1 moL'L MgC1, to 100 mL with water, and adjust the pH to 9.8 with KOH.
Reagent C: Dilute 12 g of tris(hydroxymethyl)aminomethane monomaleate to 500 mL with water. Adjust the pH to 6.0 with KOH and store at 2-8 #{176}C.
Sample preparation. Before analysis, centriftige each sample at 500 x g for 5 mm and filter through a serum separator.
Phospholipid standard. Prepare the 0.5 mmolIL phosphatidyiglycerol standard by dissolving 18.5 mg of phosphatidyl-DL-glycerol in 10 mL of a chloroform:methanol mixture (98:2 by vol) and diluting to 50 mL with the same mixture.
Evaporate aliquots of this stock phospholipid standard to 
Phospholipid extraction.
To the 2 mL final volume in each tube after lipase hydrolysis, add 2 mL of methanol (at 1-mm intervals between tubes), vortex-mix for 30 s, add 4 mU of chloroform, and promptly vortex-mix. Then vortex-mix the contents of each tube an additional minute and separate the phases by centrifuging (500 x g, 10 mm). Remove the chloroform layer and wash the methanol/water phase with an additional 4 mL of chloroform. Combine the two chloroform extracts and evaporate them under nitrogen in a 60 #{176}C water bath.
Alkaline hydrolysis of PG. Add 1 mU of reagent A to the residue from the chlorotOrm extract of AF, standards, or blanks and place the capped tubes in a heating block at 100 #{176}C for 30 mm. After 5 mm, vortex-mix the sample for 10 s to ensure that the lipid residue is in solution. Cool the solution to room temperature and neutralize a 100-L aliquot of it with 50 U of 1 molIL HCL. Add 1 mL of reagent B in preparation for the glycerol analysis.
Glycerol analysis.
Phosphatidyiglycerol is the only phospholipid in AF that contains a glycerol component that is liberated by mild alkaline hydrolysis. Triglyceride is degraded to glycerol and fatty acids by lipase treatment, before extraction; therefore, the glycerol generated by alkaline hydrolysis is derived only from phosphatidylglycerol.
This liberated glycerol is measured by an enzymatic radioassay similar to the procedure for choline (12) 
Results and Discussion
Quantitation of PG
Measurement
of PG by our method is similar in principle to the assay for lecithin in AF (12) . In that assay, lecithin is hydrolyzed in alkali to form choline, which is measured by an enzymic radioassay. In the PG analysis, alklaine hydrolysis produces glycerol, which is then quantitated by an enzymic radiochemical procedure. The extent of hydrolysis depends on both temperature and concentration of alkali. In 500 mrnolIL KOH at 100 #{176}C, 50 nmol of PG is maximally hydrolyzed to glycerol in 20 mm. Glycerol is stable for 60 mm under these conditions. To prove that PG was quantitatively degraded to glycerol, we showed that the glycerol formed was stochiometrically equivalent to the amount of PG added, within the range of 5-50 nmol.
The stochiometric equivalence between PG added and glycerol formed was independently confirmed by a colonmetric assay for glycerol (triglyceride assay, Baker Instr. Corp.). The results showed that conversion of PG to glycerol during the hydrolysis was 92% of the theoretical results.
To investigate whether free glycerol in AF interferes with PG analysis, we assayed for exogenously added glycerol in AF without alkaline hydrolysis. No glycerol was detected; therefore we concluded that it is not extracted from AF under our assay conditions.
Specificity of PG Analysis
None of the phospholipids in AF (except P1), when added to the assay medium, interfere with the analysis for PG (Table 1) . Interestingly, exogenously added P1 from several commercial suppliers cross reacted in the assay, but we proved by three lines of evidence that P1 itself does not interfere with the PG assay:
(a) Neither hydrolysis product of PI-phosphatidic acid or inositol-interfered with the radioenzyme assay for glycerol. The glycerol kinase reaction is highly specific and did not catalyze the phosphorylation of inositol. (b) The interference of commercial P1 in the PG assay was due to contamination with a glycerol-containing substance, as we proved by hydrolyzing P1 (from Sigma) in mild alkali (as in the PG assay) and assaying the products for glycerol by using a "triglyceride" assay (Baker Triglyceride assay; see Methods). The assay showed that all P1 preparations contained 0.7 mol of glycerol per mole of P1. Typically, 0.55 mol of glycerol per mole of P1 was measured in the radioenzyme assay for PG. Thus, all P1 interference could be accounted for by glycerol contamination.
(c) Removal of glycerol from P1 eliminated the interference in the PG assay. We removed the glycerol from P1 after hydrolysis by preincubation with ATP and glycerol kinase.
When the resulting material was subjected to the radioenzyme analysis for PG, there was no cross reaction. To ensure that preincubation with unlabeled ATP did not dilute out the radioactivity in the enzymic assay for PG, we ran suitable PG controls after they were treated in the identical manner.
These experiments show that endogenous P1 in amniotic fluid does not interfere with the analysis for PG. nal standard (20 nmol of PG) was routinely added to patients' specimens to correct for small variations in recovery among specimens.
Recovery Studies
Precision Studies
Multiple analyses of four AF pools were done to determine the within-and between-run precision of the PG assay (Table 2) .
PG Content vs L'S Ratio
We assayed for PG in AF from seven normal and 20 complicated pregnancies and compared these values with those for the US ratio ( Figure 1) as measured by the method of Gluck et al. (4) . Regression analysis showed a weak correlation (r = .550). However, despite the poor quantitative correlation, in 15 of 16 cases where the US ratio exceeded 2.0 the PG concentration was at least 10 molIU of AF. Therefore, if one assumes that an US ratio exceeding 2.0 correlates with fetal lung maturity, then a PG concentration of 10 tzmol/L (nmollmU) or greater may relate similarly to lung maturity. Because in complicated pregnancies the US ratio has questionable reliability, the PG concentration required for fetal lung maturity must be based on independent evidence. To this end we examined 15 cases in which infants were delivered within two days of the analyses. Of these, there was one case of RDS with a PG value of 3 moVU of AF and an US ratio of 0.5. Of the 14 neonates without RDS, all but one had a PG value 10 mol!L of AF. In two cases with transitional L/S ratios of 1.5 and 1.9 and PG values of 5.0 and 11.9 mol/L of AF, respectively, no RDS was apparent upon delivery. These preliminary data suggest that values for PG 10 mol!U correlate with fetal lung maturity. 
PG Content vs Weeks of Gestation
The PG content of AF as a function of gestational age is shown in Figure 2 . Prior to 34.5-35 weeks, little to no PG (s2 prnolIU of AF) was present in AF. It increases markedly between 35 and 36 weeks.
Adequate amounts of L, PG, and P1 must be present in order to lower alveolar surface tension most efficiently (18) . Lecithin is an effective surfactant alone, but it may require PG and P1 as stabilizers (13, 17, 18) . Surfactant with P1 and PG is superior to P1 alone (18) . P1 concentrations peak at 35-36 weeks of gestation, then decline, whereas PG appears in AF at that time and increases rapidly to become the second most abundant phospholipid in the alveolar surfactant (2, 17, 18) . The measurement of PG in conjunction with or in lieu of the U/S ratio may prove to be a more reliable indicator of fetal lung maturity.
Furthermore, contamination with blood will not interfere with the analysis for PG in AF (2, 5, 17, 18) . US ratios were measured at the Gyn-Endocrine Laboratory,
Yale-New Haven Medical Center, New Haven, CT.
